Clinic
The Aroostook Medical Center
The Aroostook Medical Center was paid $526K by Medicaid between Jan 2018 and Aug 2024, across 30 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 96% of everything it billed.
33Billing provider infoTHE AROOSTOOK MEDICAL CENTER
PRESQUE ISLE, ME 04769
PRESQUE ISLE, ME 04769
33aNPI1982723037assigned 03/28/2007
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$526K
24GClaims76,514
24DCodes billed30
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Maine
Rank by total paid#19 of 20
Median peer was paid$1.49M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,866 | $56K | |
| 2019 | 13,307 | $76K | |
| 2020 | 14,591 | $71K | |
| 2021 | 12,909 | $75K | |
| 2022 | 12,641 | $111K | |
| 2023 | 9,543 | $89K | |
| 2024incomplete | 4,657 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 96% | 21,679 | 1,699 | $507K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | <1% | 4,234 | 383 | $4K |
| 83970 | <1% | 547 | 507 | $2K | |
| 84520 | <1% | 3,508 | 1,697 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 93 | 33 | $1K |
| 82728 | <1% | 921 | 829 | $1K | |
| 84132 | <1% | 2,128 | 1,689 | $943.37 | |
| 82310 | <1% | 2,049 | 1,689 | $894.44 | |
| 84460 | <1% | 1,836 | 1,688 | $885.84 | |
| 84100 | <1% | 2,076 | 1,689 | $872.25 | |
| 84075 | <1% | 1,837 | 1,688 | $865.16 | |
| 82565 | <1% | 1,836 | 1,688 | $851.81 |
18 more codes
| 82374 | <1% | 1,837 | $812.07 | |
| 84295 | <1% | 1,836 | $803.15 | |
| 83550 | <1% | 923 | $656.15 | |
| 82040 | <1% | 1,838 | $488.40 | |
| 83540 | <1% | 923 | $485.76 | |
| 82947 | <1% | 910 | $474.29 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 374 | $320.19 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 93 | $297.50 |
| 82962 | <1% | 998 | $229.67 | |
| G0008 | Administration of influenza virus vaccine | <1% | 73 | $120.85 |
| 85018 | <1% | 491 | $97.66 | |
| 90686 | <1% | 15 | $57.09 | |
| 87340 | <1% | 39 | $41.78 | |
| J2501 | Injection, paricalcitol, 1 mcg | 0% | 7,732 | $0.00 |
| A4657 | Syringe, with or without needle, each | 0% | 1,699 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 0% | 12,175 | $0.00 |
| 86704 | 0% | 13 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 1,801 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOBSON, SAMUEL (VP/CFO)
| Provider | Location | Paid |
|---|---|---|
| The Aroostook Medical Center | Presque Isle, ME | $38.59M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.